Literature DB >> 19894076

Expression analyses of the mitochondrial complex I 75-kDa subunit in early onset schizophrenia and autism spectrum disorder: increased levels as a potential biomarker for early onset schizophrenia.

Regina Taurines1, Johannes Thome, J Catharina Duvigneau, Sarah Forbes-Robertson, Liya Yang, Karin Klampfl, Jasmin Romanos, Sabine Müller, Manfred Gerlach, Claudia Mehler-Wex.   

Abstract

Searching for a peripheral biological marker for schizophrenia, we previously reported on elevated mitochondrial complex I 75-kDa subunit mRNA-blood concentrations in early onset schizophrenia (EOS). The aim of this study was to further evaluate the utility of this gene as a potential marker for schizophrenia. Both-schizophrenia and autism-are suggested to be neuronal maldevelopmental disorders with reports of mitochondrial dysfunction and increased oxidative stress. Therefore we have investigated the expression levels of mitochondrial complex I 75-kDa subunit mRNA in whole blood of children with autistic spectrum disorder (ASD) and a group of adolescent acute first-episode EOS patients in comparison to matched controls. We have found that compared to the respective controls only the group of EOS patients-and not the ASD group-showed a significantly altered expression of the complex I 75-kDa subunit mRNA. Although further studies are necessary to test for the specificity of this marker, our findings point to the potential use of the mitochondrial complex I as a biomarker for schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19894076     DOI: 10.1007/s00787-009-0074-z

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  46 in total

1.  Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia.

Authors:  Frank A Middleton; Karoly Mirnics; Joseph N Pierri; David A Lewis; Pat Levitt
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

2.  The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.

Authors:  C Lord; S Risi; L Lambrecht; E H Cook; B L Leventhal; P C DiLavore; A Pickles; M Rutter
Journal:  J Autism Dev Disord       Date:  2000-06

3.  Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats.

Authors:  Ana O Fagundes; Gislaine T Rezin; Francine Zanette; Eliane Grandi; Lara C Assis; Felipe Dal-Pizzol; João Quevedo; Emilio L Streck
Journal:  Int J Dev Neurosci       Date:  2006-12-22       Impact factor: 2.457

4.  Biochemical and molecular effects of chronic haloperidol administration on brain and muscle mitochondria of rats.

Authors:  A Barrientos; C Marín; O Miró; J Casademont; M Gómez; V Nunes; E Tolosa; A Urbano-Márquez; F Cardellach
Journal:  J Neurosci Res       Date:  1998-08-15       Impact factor: 4.164

Review 5.  Mitochondria, synaptic plasticity, and schizophrenia.

Authors:  Dorit Ben-Shachar; Daphna Laifenfeld
Journal:  Int Rev Neurobiol       Date:  2004       Impact factor: 3.230

6.  Mitochondrial dysfunction in autistic patients with 15q inverted duplication.

Authors:  Pauline A Filipek; Jenifer Juranek; Moyra Smith; Lee Z Mays; Erica R Ramos; Maureen Bocian; Diane Masser-Frye; Tracy M Laulhere; Charlotte Modahl; M Anne Spence; J Jay Gargus
Journal:  Ann Neurol       Date:  2003-06       Impact factor: 10.422

7.  Cingulate gyrus volume and metabolism in the schizophrenia spectrum.

Authors:  M Mehmet Haznedar; Monte S Buchsbaum; Erin A Hazlett; Lina Shihabuddin; Antonia New; Larry J Siever
Journal:  Schizophr Res       Date:  2004-12-01       Impact factor: 4.939

8.  Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia.

Authors:  Erin A Hazlett; Monte S Buchsbaum; Eileen Kemether; Rachel Bloom; Jimcy Platholi; Adam M Brickman; Lina Shihabuddin; Cheuk Tang; William Byne
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

9.  Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features.

Authors:  R E Gur; P D Mozley; S M Resnick; L H Mozley; D L Shtasel; F Gallacher; S E Arnold; J S Karp; A Alavi; M Reivich
Journal:  Arch Gen Psychiatry       Date:  1995-08

10.  Relative glucose metabolic rate higher in white matter in patients with schizophrenia.

Authors:  Monte S Buchsbaum; Bradley R Buchsbaum; Erin A Hazlett; M Mehmet Haznedar; Randall Newmark; Cheuk Y Tang; Patrick R Hof
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112

View more
  12 in total

Review 1.  Genetic association studies of antioxidant pathway genes and schizophrenia.

Authors:  Kodavali V Chowdari; Mikhil N Bamne; Vishwajit L Nimgaonkar
Journal:  Antioxid Redox Signal       Date:  2010-11-01       Impact factor: 8.401

Review 2.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

Review 3.  Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics.

Authors:  Chi-Yu Lai; Elizabeth Scarr; Madhara Udawela; Ian Everall; Wei J Chen; Brian Dean
Journal:  World J Psychiatry       Date:  2016-03-22

4.  Is the PentaBDE replacement, tris (1,3-dichloro-2-propyl) phosphate (TDCPP), a developmental neurotoxicant? Studies in PC12 cells.

Authors:  Laura V Dishaw; Christina M Powers; Ian T Ryde; Simon C Roberts; Frederic J Seidler; Theodore A Slotkin; Heather M Stapleton
Journal:  Toxicol Appl Pharmacol       Date:  2011-01-19       Impact factor: 4.219

5.  Mitochondrial Dysfunction in Schizophrenia: Determination of Mitochondrial Respiratory Activity in a Two-Hit Mouse Model.

Authors:  Cécile Monpays; Jessica Deslauriers; Philippe Sarret; Sylvain Grignon
Journal:  J Mol Neurosci       Date:  2016-03-31       Impact factor: 3.444

6.  Treatment of early onset schizophrenia: recent trends, challenges and future considerations.

Authors:  Nora S Vyas; Nitin Gogtay
Journal:  Front Psychiatry       Date:  2012-04-02       Impact factor: 4.157

Review 7.  Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.

Authors:  D A Rossignol; R E Frye
Journal:  Mol Psychiatry       Date:  2011-01-25       Impact factor: 15.992

Review 8.  The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment.

Authors:  Anna Giménez-Palomo; Seetal Dodd; Gerard Anmella; Andre F Carvalho; Giselli Scaini; Joao Quevedo; Isabella Pacchiarotti; Eduard Vieta; Michael Berk
Journal:  Front Psychiatry       Date:  2021-07-06       Impact factor: 4.157

9.  Do nuclear-encoded core subunits of mitochondrial complex I confer genetic susceptibility to schizophrenia in Han Chinese populations?

Authors:  Xiao Li; Wen Zhang; Jinsong Tang; Liwen Tan; Xiong-jian Luo; Xiaogang Chen; Yong-Gang Yao
Journal:  Sci Rep       Date:  2015-06-08       Impact factor: 4.379

Review 10.  Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects.

Authors:  Lilach Toker; Galila Agam
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-24       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.